Eli Lilly and Company
Eli Lilly's experimental treatment, bamlanivimab, is a monoclonal antibody therapy, and is cleared for those 12 and older with mild-to-moderate coronavirus cases.
In a setback for one of the most promising treatment approaches, officials found a low chance that the drug would prove helpful for hospitalized patients.
The group will start with a protest outside the Eli Lilly headquarters in Indianapolis.
